ClinicalTrials.Veeva

Menu

Treatment of Androgenic Alopecia in Males

L

Lexington International

Status

Completed

Conditions

Hair Loss
Male Pattern Baldness
Androgenetic Alopecia

Treatments

Device: Control device
Device: HairMax LaserComb

Study type

Interventional

Funder types

Industry

Identifiers

NCT00947219
9.12 2009-M-02

Details and patient eligibility

About

The purpose of this study is to evaluate the change in terminal hair count at 16 and 26 weeks compared to baseline measurements.

Full description

This is randomized, double-blind, control device clinical study across 3 sites, evaluating changes in terminal hair-count in the evaluation zone having evidence of androgenetic alopecia (miniaturized hair).

The trial will involve approximately 75 male subjects who have been diagnosed with androgenetic alopecia, who are between 25 and 60 years of age, have Fitzpatrick Skin Types I-IV, with classifications of Norwood-Hamilton IIa to V, have active hair loss within the last 12 months.

Subjects will use the device on three non-consecutive days a week as directed per device for 26 weeks treatment duration.

Safety analysis will be assessed based on the reports of adverse events during study.

Enrollment

79 patients

Sex

Male

Ages

25 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Diagnosis of androgenetic alopecia
  • Fitzpatrick Skin Types I-IV
  • Norwood-Hamilton IIa to V
  • Active hair loss within last 12 months

Exclusion criteria

  • Photosensitivity to laser light
  • Malignancy in the target area

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

79 participants in 3 patient groups

HairMax LaserComb 2009, 12 Beam
Active Comparator group
Description:
Low Level Laser Medical Device 2009 with 12 laser beams
Treatment:
Device: HairMax LaserComb
HairMax LaserComb 2009 9 Beam
Active Comparator group
Description:
Low Level Laser Mecial Device 2009 with 9 laser beams
Treatment:
Device: HairMax LaserComb
Control device
Active Comparator group
Description:
The control device appears identical to the active device, but utilizes 9 LED lights instead of laser lights. The randomized devices are blinded to the study investigator and distributed in a blinded manner to the participants.
Treatment:
Device: Control device

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems